Putting the award page together from the records…
Putting the award page together from the records…
Baxter Healthcare Corporation received this contract from Aspr/Orm-Sns, Office of Assistant Secretary for Preparedness and Response: $18.83M obligated so far for drugs and biologicals. It runs to 2027-08-31, or to 2030-08-31 if every option is exercised.
Key facts · data as of Oct 22, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.
Cite this page: SpendQuery, Award 75A50325C00013, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_75A50325C00013_7505_-NONE-_-NONE-
Baxter Healthcare Corporation: all federal awards · Department of Health and Human Services: spending · Aspr/Orm-Sns: what it buys · The follow-on: recompete brief
SODIUM CHLORIDE (NACL), 0.9% FOR INJECTION, 100ML SOLUTION FLEXI-BAG
Up for re-bid: ends 2027-08-31. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
2 actions since 2025-08-27. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-24 | P00001 | Option exercised | $14.45M | EXERCISE OPTIONAL ORDERING PERIOD 1 FOR SODIUM CHLORIDE, (NACL), 0.9% FOR INJECTION, 100ML SOLUTION FLEXI-BAG. |
| 2025-08-27 | 0 | $4.38M | SODIUM CHLORIDE (NACL), 0.9% FOR INJECTION, 100ML SOLUTION FLEXI-BAG |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗